JPH0575066B2 - - Google Patents
Info
- Publication number
- JPH0575066B2 JPH0575066B2 JP6269485A JP6269485A JPH0575066B2 JP H0575066 B2 JPH0575066 B2 JP H0575066B2 JP 6269485 A JP6269485 A JP 6269485A JP 6269485 A JP6269485 A JP 6269485A JP H0575066 B2 JPH0575066 B2 JP H0575066B2
- Authority
- JP
- Japan
- Prior art keywords
- histamine
- solution
- orthophthalaldehyde
- separation column
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 86
- 229960001340 histamine Drugs 0.000 claims description 43
- 238000006243 chemical reaction Methods 0.000 claims description 38
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 21
- 238000000926 separation method Methods 0.000 claims description 19
- 238000004458 analytical method Methods 0.000 claims description 16
- 239000007853 buffer solution Substances 0.000 claims description 16
- 239000003480 eluent Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 238000004811 liquid chromatography Methods 0.000 claims description 9
- 238000002835 absorbance Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 238000005277 cation exchange chromatography Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 11
- 125000003277 amino group Chemical group 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 description 5
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000002883 imidazolyl group Chemical group 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000004452 microanalysis Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 101100493714 Caenorhabditis elegans bath-47 gene Proteins 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 229960004931 histamine dihydrochloride Drugs 0.000 description 1
- PPZMYIBUHIPZOS-UHFFFAOYSA-N histamine dihydrochloride Chemical compound Cl.Cl.NCCC1=CN=CN1 PPZMYIBUHIPZOS-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- WLGDAKIJYPIYLR-UHFFFAOYSA-N octane-1-sulfonic acid Chemical compound CCCCCCCCS(O)(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
【発明の詳細な説明】
(イ) 産業上の利用分野
この発明は、ヒスタミンの分析方法及び装置に
関する。さらに詳しくは、血しよう、血球等の各
種試料中のヒスタミンを高感度に定性・定量でき
るヒスタミンの分析方法及び装置に関する。DETAILED DESCRIPTION OF THE INVENTION (a) Field of Industrial Application This invention relates to a method and apparatus for analyzing histamine. More specifically, the present invention relates to a histamine analysis method and apparatus that can qualitatively and quantitatively quantify histamine in various samples such as blood plasma and blood cells with high sensitivity.
(ロ) 従来技術
従来から、アミノ酸のごときアミノ基を有する
化合物の分析に、オルトフタルアルデヒドとメル
カプトエタノールのごときチオール基含有化合物
を用いた方法が行なわれている。この方法は、例
えばカラムで分離した各アミノ酸成分、ことに高
速液体クロマトグラフイにより分離した各成分を
オルトフタルアルデヒド及びメルカプトエタノー
ルと反応させて発蛍光性の化合物を生成させ、こ
の化合物の蛍光光度や吸光光度に基づいて定性・
定量を行なう方法である。そして、この発明の対
象とするヒスタミンもアミノ基を有する化合物で
あるため、上記と同様にオルトフタルアルデヒド
及びチオール基含有化合物と反応させて分析を行
なう方法が採用されている。(b) Prior Art Conventionally, methods using thiol group-containing compounds such as orthophthalaldehyde and mercaptoethanol have been used to analyze compounds having amino groups such as amino acids. In this method, for example, each amino acid component separated by a column, especially each component separated by high performance liquid chromatography, is reacted with orthophthalaldehyde and mercaptoethanol to produce a fluorescent compound, and the fluorescence intensity of this compound is Qualitative and absorbance based on
This is a method for quantitative determination. Since histamine, which is the object of the present invention, is also a compound having an amino group, a method of reacting it with orthophthalaldehyde and a thiol group-containing compound and analyzing it is adopted in the same manner as above.
しかしながら、かかる方法においては、反応試
薬となるオルトフタルアルデヒド及びチオール基
含有化合物と反応する試薬溶媒中の不純物等の影
響により、蛍光や吸光のバツクグラウンドが高
く、高感度の分析を行なうことができず、ことに
ヒスタミンについてのpgオーダーの微量分析を
行なうことができない。 However, in this method, the background of fluorescence and light absorption is high due to the influence of impurities in the reagent solvent that reacts with ortho-phthalaldehyde and thiol group-containing compounds, which are the reaction reagents, and highly sensitive analysis cannot be performed. In particular, it is not possible to perform microanalysis of histamine on the pg order.
この点に関し、高速液体クロマトグラフイー等
の分離を行なう前に、上記二種の反応試薬あるい
はオルトフタルアルデヒド試薬のみと反応させて
発蛍光性化合物を生成させた後、分離を行なつて
該発蛍光性化合物を蛍光又は吸光光度に基づいて
検出する方法も提案されている。しかしながら、
この方法においては、ヒスタミンのアミノ基のみ
ならずイミダゾール基に起因する副反応によつて
複数個のピークとなり、定量を行なうことが極め
て困難であつた。 In this regard, before performing separation using high-performance liquid chromatography, etc., a fluorescent compound is produced by reacting with only the above two reaction reagents or orthophthalaldehyde reagent, and then separation is performed to generate the fluorescent compound. Methods for detecting fluorescent compounds based on fluorescence or absorbance have also been proposed. however,
In this method, multiple peaks were generated due to side reactions caused not only by the amino group of histamine but also by the imidazole group, making quantitative determination extremely difficult.
この発明はかような状況に鑑みなされたもので
あり、ヒスタミンを高感度に分析できる分析方法
を提供しようとするものである。 This invention was made in view of the above situation, and it is an object of the present invention to provide an analysis method that can analyze histamine with high sensitivity.
本発明者は、鋭意研究を行なつた結果、ヒスタ
ミンを対象とした場合、特定の条件下におい、上
記二種の反応試薬を用いることなく単にオルトフ
タルアルデヒドと混合反応させることにより発蛍
光性の溶液が得られ、しかもオルトフタルアルデ
ヒドを酸性緩衝液に溶解し、PH7〜12の緩衝液と
別々に送液することによりバツクグラウンドの蛍
光及び吸光が二種の反応試薬を用いた従来法に比
して著しく低下する事実を見出した。 As a result of extensive research, the present inventors have found that when histamine is used as a target, under specific conditions, the fluorescent property can be reduced by simply reacting it with orthophthalaldehyde without using the above two reaction reagents. A solution is obtained, and by dissolving orthophthalaldehyde in an acidic buffer and feeding it separately from a buffer with a pH of 7 to 12, background fluorescence and light absorption are reduced compared to the conventional method using two reaction reagents. We found that there was a significant decrease in
(ハ) 発明の構成
かくしてこの発明によれば、ヒスタミン含有液
を、PH7〜12の緩衝液の存在下、オルトフタルア
ルデヒドと緩和な温度下で混合反応させることに
より発蛍光性の反応液を得、この反応液の蛍光光
度又は吸光光度を測定することによりヒスタミン
を分析することを特徴とするヒスタミンの分析方
法が提供される。(C) Structure of the Invention Thus, according to the present invention, a fluorescent reaction solution is obtained by mixing and reacting a histamine-containing solution with orthophthalaldehyde in the presence of a buffer solution with a pH of 7 to 12 at a mild temperature. , a method for analyzing histamine is provided, which comprises analyzing histamine by measuring the fluorescence intensity or absorbance of this reaction solution.
この発明の最も特徴とする点は、メルカプトエ
タノールのごときチオール基(SH基)を含有す
る化合物を全く用いることなく、ヒスタミンをオ
ルトフタルアルデヒドと溶液下で混合して発蛍光
性の化合物を得る点にある。通常のアミノ酸の場
合、チオール基含有化合物を用いずにかかる発蛍
光性の化合物は容易に生成しない。従つてヒスタ
ミンとオルトフタルアルデヒドの反応は特異的な
ものと考えられる。この反応は主としてヒスタミ
ンのアミノ基及びイミダゾール環とオルトフタル
アルデヒドとの反応に基づき従来の発蛍光性化合
物とは異なる発蛍光性化合物が生成しているもの
と考えられるが、その詳細については明らかでな
い。しかしながら、少なくとも上記条件下でヒス
タミンとオルトフタルアルデヒドとを共存させる
ことにより、発蛍光性の化合物が得られ、これを
用いることによりヒスタミンを分析することが可
能となる。 The most distinctive feature of this invention is that a fluorescent compound is obtained by mixing histamine with orthophthalaldehyde in solution without using any compound containing a thiol group (SH group) such as mercaptoethanol. It is in. In the case of ordinary amino acids, such fluorescent compounds cannot be easily produced without using a thiol group-containing compound. Therefore, the reaction between histamine and orthophthalaldehyde is considered to be specific. This reaction is thought to be mainly based on the reaction between the amino group and imidazole ring of histamine and orthophthalaldehyde, and a fluorescent compound different from conventional fluorescent compounds is generated, but the details are not clear. . However, by allowing histamine and orthophthalaldehyde to coexist at least under the above conditions, a fluorescent compound can be obtained, and by using this, it becomes possible to analyze histamine.
この発明におけるヒスタミンとオルトフタルア
ルデヒドとの反応はPH7〜12の緩衝液の存在下で
行なわれ、ことにPH7〜8の緩衝液下で行なうの
が好ましい。また、緩衝液としては、通常、ホウ
酸緩衝液あるいはリン酸緩衝液を適用するのが適
しており、例えば前者の場合にはホウ酸塩類の濃
度は、混合反応系中で50〜200mMとするのが好
ましい。 The reaction between histamine and orthophthalaldehyde in the present invention is carried out in the presence of a buffer solution with a pH of 7 to 12, preferably in the presence of a buffer solution with a pH of 7 to 8. In addition, as a buffer solution, it is usually suitable to apply a borate buffer or a phosphate buffer; for example, in the case of the former, the concentration of borate should be 50 to 200mM in the mixed reaction system. is preferable.
一方、反応試薬となるオルトフタルアルデヒド
は混合反応系中で0.001〜0.1wt%となるように調
整するのに適しており、0.01〜0.02wt%とするの
が好ましい。反応系中で0.001wt%未満あるいは
0.1wt%を越える濃度であると、蛍光強度が低下
するため好ましくない。オルトフタルアルデヒド
は通常、PH2〜5のリン酸、酢酸又はクエン酸緩
衝液に溶解した状態(有機溶媒が含まれていても
よい)で混合反応に供される。 On the other hand, ortho-phthalaldehyde as a reaction reagent is suitable for adjusting to 0.001 to 0.1 wt% in the mixed reaction system, and preferably 0.01 to 0.02 wt%. less than 0.001wt% or
If the concentration exceeds 0.1 wt%, the fluorescence intensity will decrease, which is not preferable. Orthophthalaldehyde is usually subjected to a mixed reaction in a state dissolved in a phosphoric acid, acetic acid, or citric acid buffer having a pH of 2 to 5 (which may contain an organic solvent).
また、混合反応は緩和な温度下で行なわれ、少
なくとも40℃以上の温度で行なうのが適してお
り、40℃〜70℃下で行なうのが好ましい。 Further, the mixing reaction is carried out at a mild temperature, suitably at a temperature of at least 40°C or higher, preferably at a temperature of 40°C to 70°C.
反応は迅速になされ、通常5〜10秒で発蛍光性
の反応液が得られる。この反応液の蛍光光度及び
吸光光度はいずれもヒスタミン濃度に対応してい
るため、これらの強度を測定することによりヒス
タミンを定量することができる。この際の測光波
長としては、蛍光光度の場合、440nm付近、吸光
光度の場合、360nm付近に設定するのが適してい
る。ただし、pgオーダの微量分析を行なうため
には蛍光光度を測定することが必要である。 The reaction is rapid, and a fluorescent reaction solution is usually obtained in 5 to 10 seconds. Since the fluorescence intensity and absorbance of this reaction solution both correspond to the histamine concentration, histamine can be quantified by measuring these intensities. In this case, it is suitable to set the photometric wavelength to around 440 nm for fluorescence intensity and around 360 nm for absorbance intensity. However, in order to perform microanalysis on the PG order, it is necessary to measure the fluorescence intensity.
なお、実際上、ヒスタミン含有液は通常、液体
クロマトグラフイことに高速液体クロマトグラフ
イで各成分に分離した後、混合反応に供するのが
好ましい。この場合に用いる液体クロマトグラフ
イ用分離カラム及び移動相としては、一般的な逆
相又は陽イオン交換クロマトグラフイ用分離カラ
ム及び移動相を用いるのが適しており、逆相クロ
マトグラフイ用のカラム及び移動相としては例え
ばシムパツクCLC−ODS及びオクタンスルホン
酸を含有する酸性リン酸緩衝液が挙げられ、陽イ
オン交換クロクトグラフイ用のカラム及び移動相
としては例えばシムパツクWCX−1及び中性リ
ン酸緩衝液が挙げられる。これらの分離はことに
ヒスタミンの高感度分析の点で好ましい。 In practice, it is preferable that the histamine-containing liquid is usually separated into its components by liquid chromatography, particularly high-performance liquid chromatography, and then subjected to a mixing reaction. As the separation column and mobile phase for liquid chromatography used in this case, it is suitable to use a separation column and mobile phase for general reversed phase or cation exchange chromatography. Columns and mobile phases include, for example, Simpack CLC-ODS and acidic phosphate buffer containing octane sulfonic acid; examples of columns and mobile phases for cation exchange chromatography include Simpack WCX-1 and neutral phosphate buffer. Examples include liquids. These separations are particularly preferred from the standpoint of highly sensitive analysis of histamine.
上記液体クロマトグラフイを用いた場合には、
溶離液流路にコイル状の混合反応管を設定し、か
つその上流にオルトフタルアルデヒド溶液及びPH
7〜12の緩衝液をそれぞれ送液しうる送液部を設
けることにより、分析を一工程で効率良く行なう
ことができる。従つてこの発明は、ヒスタミン含
有試料の導入部を介して液体クロマトグラフイ用
分離カラムに接続される移動相流路と、該分離カ
ラムから延設され蛍光光度又は吸光光度測定手段
を備えた検出部に接続される溶離液流路を有し、
該溶離液流路にコイル状の混合反応管を設定しか
つその上流にオルトフタルアルデヒド溶液及びPH
7〜12の緩衝液の送液部を付設したことを特徴と
するヒスタミン分析装置をも提供するものであ
る。この際のコイル状の混合反応管は内径0.3〜
0.5mmのもので内容量200〜500μのものを用いる
のが好ましい。また、混合反応が効率良く行なわ
れるように、溶離液流路ことに混合反応管附近に
は40℃〜70℃に加温しうる加熱手段を付設するこ
とが適している。 When using the above liquid chromatography,
A coiled mixing reaction tube is set in the eluent flow path, and orthophthalaldehyde solution and PH
By providing a liquid feeding section capable of feeding 7 to 12 buffer solutions, analysis can be performed efficiently in one step. Therefore, the present invention provides a mobile phase flow path connected to a separation column for liquid chromatography via an inlet for a histamine-containing sample, and a detection device extending from the separation column and equipped with fluorescence or absorbance measurement means. an eluent flow path connected to the
A coiled mixing reaction tube is set in the eluent flow path, and an orthophthalaldehyde solution and a PH
The present invention also provides a histamine analyzer characterized in that it is equipped with 7 to 12 buffer solution feeding sections. In this case, the coiled mixing reaction tube has an inner diameter of 0.3~
It is preferable to use a 0.5 mm one with an internal capacity of 200 to 500 μm. Further, in order to carry out the mixing reaction efficiently, it is suitable to provide a heating means capable of heating the mixture to 40° C. to 70° C. in the eluent flow path and in the vicinity of the mixing reaction tube.
(ホ) 実施例
第1図に示す1は、この発明の方法を実施する
ヒスタミン分析装置を示し、基本的に、ポンプ2
2により試料導入部21を介して移動相23を液
体クロマトグラフイ用分離カラム3へ移送する移
動相流路2と、分離カラム3からの溶離液を蛍光
光度計5に移送する溶離液流路4とから構成され
てなり、該溶離液流路4の一部にはコイル状の混
合反応管41が設定され、かつその手前にはオル
トフタルアルデヒド溶液43とPH7〜12の緩衝液
44の試薬導入管42が付設されてなる。なお、
分離カラム3は恒温槽31により適度な分離温度
に加温されており、混合反応管41を含む溶離液
流路及び導入管42の一部は恒温槽47により40
℃〜70℃に加温されている。また46はオルトフ
タルアルデヒド溶液3と緩衝液44との予備混合
用のコイル状混合管を示す。(e) Example 1 shown in FIG. 1 shows a histamine analyzer for carrying out the method of the present invention, which basically consists of a pump 2
2, the mobile phase channel 2 transfers the mobile phase 23 to the separation column 3 for liquid chromatography via the sample introduction part 21, and the eluent channel 2 transfers the eluent from the separation column 3 to the fluorometer 5. 4, a coiled mixing reaction tube 41 is set in a part of the eluent flow path 4, and in front of the coiled mixing reaction tube 41, reagents of an orthophthalaldehyde solution 43 and a buffer solution 44 with a pH of 7 to 12 are placed. An introduction pipe 42 is attached. In addition,
The separation column 3 is heated to an appropriate separation temperature by a constant temperature bath 31, and a part of the eluent flow path including the mixing reaction tube 41 and the introduction tube 42 are heated to 40℃ by a constant temperature bath 47.
It is heated to between ℃ and 70℃. Further, 46 indicates a coiled mixing tube for pre-mixing the orthophthalaldehyde solution 3 and the buffer solution 44.
この装置1において、まず移動相23がポンプ
22により一定流量で分離カラム3及び溶離液流
路4を通じてドレイン52に流されかつオルトフ
タルアルデヒド溶液43及び緩衝液44がポンプ
45により一定流量で溶離液流路4に注入され
る。この際の蛍光光度計5の出力は記録計51で
記録されベースライン出力となる。この状態でヒ
スタミン含有試料を試料導入部21から流路2内
に注入することにより、ヒスタミンが他成分と分
離され、溶離液流路4の混合反応管41中でオル
トフタルアルデヒドと充分に混合反応されてヒス
タミンが発蛍光性の誘導体に変換され、この発蛍
光性の溶離液の蛍光光度が蛍光光度計5で測定さ
れ記録計にピークとして出力されることとなる。
なお、試薬導入管42はオルトフタルアルデヒド
溶液43及び緩衝液44についてそれぞれ別個に
設けられ流路4へ接続されていてもよい。いずれ
にせよ、流路4中へ別々に注入するか、又は流路
4中への注入直前に混和して注入することによ
り、反応用の試薬を用時調整する状態となり、バ
ツクグラウンドをより低減化させることができか
つ変動も防止することができる。 In this apparatus 1, first, a mobile phase 23 is flowed at a constant flow rate by a pump 22 through a separation column 3 and an eluent flow path 4 to a drain 52, and an ortho-phthalaldehyde solution 43 and a buffer solution 44 are supplied to an eluate by a pump 45 at a constant flow rate. It is injected into the channel 4. The output of the fluorometer 5 at this time is recorded by the recorder 51 and becomes the baseline output. By injecting a histamine-containing sample into the channel 2 from the sample introduction part 21 in this state, histamine is separated from other components and is sufficiently mixed and reacted with orthophthalaldehyde in the mixing reaction tube 41 of the eluent channel 4. Histamine is converted into a fluorescent derivative, and the fluorescence intensity of this fluorescent eluent is measured by a fluorometer 5 and output as a peak to a recorder.
Note that the reagent introduction tube 42 may be provided separately for the orthophthalaldehyde solution 43 and the buffer solution 44 and connected to the channel 4. In any case, by injecting the reagents into the channel 4 separately or by mixing and injecting them immediately before injection into the channel 4, the reaction reagents can be prepared just before use, further reducing the background. It is also possible to prevent fluctuations.
上記装置1を用いてヒスタミン含有試料の分析
を行なつた結果を以下に説明する。装置は、高速
液体クロマトグラフ装置LC−5A(島津製作所(株)
製)を基本的に用いて構成し、混合反応管41と
しては内径0.5mm、長さ2mのステンレス製のコ
イル状チユーブを用いた。また、ポンプ45は
BRR−2A(島津製作所(株)製)を用い、蛍光光度
計はRF−540(島津製作所(株)製)を用い励起波長
360nm、測光波長440nmで蛍光検出を行なつた。
詳細な条件は以下の通りである。 The results of analyzing a histamine-containing sample using the apparatus 1 described above will be explained below. The device is a high performance liquid chromatograph device LC-5A (Shimadzu Corporation).
The mixing reaction tube 41 was a stainless steel coiled tube with an inner diameter of 0.5 mm and a length of 2 m. In addition, the pump 45
BRR-2A (manufactured by Shimadzu Corporation) was used, and the fluorometer was RF-540 (manufactured by Shimadzu Corporation), and the excitation wavelength was
Fluorescence detection was performed at 360 nm and a photometric wavelength of 440 nm.
The detailed conditions are as follows.
分離カラム3:シムパツクCLC−ODS(内径6.0
mm×150mm長)
カラム温度:55℃
移動相23:1mMオクタンスルホン酸ナトリ
ウムを含有する10mM酢酸ナトリウム(PH
4.4)とエタノールの混合液、流量1.5ml/分
オルトフタルアルデヒド溶液43:0.3%のオ
ルトフタルアルデヒドのエタノール溶液と
10mM酢酸ナトリウム(PH4.4)の6:100の
混合溶液、注入量0.25ml/分
緩衝液44:PH9.2の500mMホウ酸緩衝液、注
入量0.25ml/分
試料:ヒスタミン二塩酸塩の100nM溶液
(0.1N塩酸)を10μ(1pmol)注入
なお、酢酸ナトリウム及びホウ酸はアミノ酸分
析用を、酢酸は試薬特級を、また、エタノールは
液体クロマトグラフイー用を和光純薬工業より購
入して用いた。オルトフタルアルデヒドは和光純
薬工業製の生化学用を使用した。ヒスタミン標準
物質は東京化成工業製の二塩酸塩を用いた。 Separation column 3: Simpack CLC-ODS (inner diameter 6.0
mm x 150 mm length) Column temperature: 55°C Mobile phase 23: 10 mM sodium acetate (PH
4.4) and ethanol, flow rate 1.5 ml/min Orthophthalaldehyde solution 43: 0.3% ethanol solution of orthophthalaldehyde and
6:100 mixture of 10mM sodium acetate (PH4.4), injection volume 0.25ml/min Buffer 44: 500mM borate buffer at pH 9.2, injection volume 0.25ml/min Sample: 100nM histamine dihydrochloride Inject 10 μ (1 pmol) of the solution (0.1N hydrochloric acid). Sodium acetate and boric acid were purchased from Wako Pure Chemical Industries for amino acid analysis, acetic acid was for reagent grade, and ethanol was for liquid chromatography. there was. Orthophthalaldehyde used was for biochemistry manufactured by Wako Pure Chemical Industries. As the histamine standard substance, dihydrochloride manufactured by Tokyo Kasei Kogyo was used.
この結果を、記録計としてデータ処理装置C−
R2AX(島津製作所(株)製)を用いた際のクロマト
グラムとして第2図に示した。図中Aがヒスタミ
ンのピークであり、バツクグラウンドの低減化に
より、少量の注入にもかかわらず明瞭なピークが
得られていることが判る。なお、Bはシステムピ
ークであり主として溶媒によるものと考えられ
る。かかる結果から、ヒスタミンの高感度分析こ
とにpgオーダーの微量分析が行なえることが判
明した。 This result is used as a recorder by the data processing device C-
Figure 2 shows a chromatogram obtained using R2AX (manufactured by Shimadzu Corporation). In the figure, A is the peak of histamine, and it can be seen that due to the reduction of the background, a clear peak was obtained despite the injection of a small amount. Note that B is a system peak and is considered to be mainly caused by the solvent. From these results, it was found that highly sensitive analysis of histamine can be performed in trace amounts on the pg order.
(ヘ) 発明の効果
この発明によれば、ヒスタミンの高感度分析を
行なうことができ、ことに蛍光を用いた際に従来
せいぜいngオーダーが限界であつた定量限界を
pgオーダーまで向上させることができる。さら
にヒスタミンのアミノ基及びイミダゾール基に起
因する反応に基づいており、単にアミノ基を有す
る夾雑成分(アミノ酸等)の妨害を受け難いため
クロマトグラフイでの保持時間が近接している他
のアミノ基含有成分の存在による影響を受け難
く、選択的にヒスタミンを分析することが可能で
ある。また悪臭を放つメルカプトエタノール等を
用いないため操作上も有利であり、しかも分析コ
ストも低減化することができる。(f) Effects of the invention According to this invention, it is possible to perform highly sensitive analysis of histamine, and in particular, it has been possible to overcome the quantification limit, which was conventionally on the order of ng at most when fluorescence was used.
It can be improved to PG order. Furthermore, it is based on the reaction caused by the amino group and imidazole group of histamine, and because it is not easily interfered with by contaminant components (such as amino acids) that simply have an amino group, the retention time in chromatography is similar to that of other amino groups. It is not easily affected by the presence of contained components, and it is possible to selectively analyze histamine. Furthermore, since mercaptoethanol, etc., which emit a bad odor, is not used, it is advantageous in terms of operation, and analysis costs can also be reduced.
第1図は、この発明の方法を実施するヒスタミ
ン分析装置を例示する構成説明図、第2図は、こ
の発明の方法により得られるヒスタミンの分析結
果を例示するクロマトグラム図である。
1……ヒスタミン分析装置、2……移動相流
路、3……液体クロマトグラフイ用分離カラム、
4……溶離液流路、5……蛍光光度計、21……
試料導入部、23……移動相、41……混合反応
管、42……試薬導入管、43……オルトフタル
アルデヒド溶液、44……PH7〜12の緩衝液、4
7……恒温槽。
FIG. 1 is a configuration explanatory diagram illustrating a histamine analyzer implementing the method of the present invention, and FIG. 2 is a chromatogram diagram illustrating the analysis results of histamine obtained by the method of the present invention. 1... Histamine analyzer, 2... Mobile phase channel, 3... Separation column for liquid chromatography,
4...Eluent channel, 5...Fluorometer, 21...
Sample introduction part, 23...Mobile phase, 41...Mixing reaction tube, 42...Reagent introduction tube, 43...Orthophthalaldehyde solution, 44...Buffer solution of pH 7 to 12, 4
7... Constant temperature bath.
Claims (1)
在下、オルトフタルアルデヒドと緩和な温度下で
混合反応させることにより発蛍光性の反応液を
得、この反応液の蛍光光度又は吸光光度を測定す
ることによりヒスタミンを分析することを特徴と
するヒスタミンの分析方法。 2 緩衝液がPH7〜8の緩衝液である特許請求の
範囲第1項に記載の分析方法。 3 混合反応を40℃〜70℃の温度下で行なう特許
請求の範囲第1項に記載の分析方法。 4 混合反応時のオルトフタルアルデヒドの濃度
が0.001〜0.1wt%である特許請求の範囲第1項に
記載の分析方法。 5 オルトフタルアルデヒドの溶媒が有機溶媒を
含有していてもよいPH5以下の緩衝液である特許
請求の範囲第1項記載の分析方法。 6 ヒスタミン含有液が、高速液体クロマトグラ
フイの分離カラムで分離された後、混合反応に供
される特許請求の範囲第1項記載の分析方法。 7 ヒスタミン含有試料の導入部を介して液体ク
ロマトグラフイ用分離カラムに接続される移動相
流路と、該分離カラムから延設され蛍光光度又は
吸光光度測定手段を備えた検出部に接続される溶
離液流路を有し、該溶離液流路にコイル状の混合
反応管を設定しかつその上流にオルトフタルアル
デヒド溶液及びPH7〜12の緩衝液の送液部を付設
したことを特徴とするヒスタミン分析装置。 8 液体クロマトグラフイ用分離カラム及び移動
相が、逆相又は陽イオン交換クロマトグラフイ用
分離カラム及び移動相である特許請求の範囲第7
項記載の分析装置。 9 溶離液流路に、40〜70℃に加温しうる加熱手
段が付設されてなる特許請求の範囲第7項記載の
分析装置。[Claims] 1. A fluorescent reaction solution is obtained by mixing and reacting a histamine-containing solution with orthophthalaldehyde in the presence of a pH 7-12 buffer solution at a mild temperature, and the fluorescence of this reaction solution is A method for analyzing histamine, which comprises analyzing histamine by measuring light intensity or absorbance. 2. The analysis method according to claim 1, wherein the buffer solution is a buffer solution with a pH of 7 to 8. 3. The analytical method according to claim 1, wherein the mixing reaction is carried out at a temperature of 40°C to 70°C. 4. The analytical method according to claim 1, wherein the concentration of orthophthalaldehyde during the mixing reaction is 0.001 to 0.1 wt%. 5. The analytical method according to claim 1, wherein the solvent for ortho-phthalaldehyde is a buffer solution with a pH of 5 or lower which may contain an organic solvent. 6. The analysis method according to claim 1, wherein the histamine-containing liquid is separated by a separation column of high performance liquid chromatography and then subjected to a mixing reaction. 7 A mobile phase flow path connected to a separation column for liquid chromatography via an introduction section for a histamine-containing sample, and a detection section extending from the separation column and equipped with a means for measuring fluorescence or absorbance. The method is characterized in that it has an eluent flow path, a coiled mixing reaction tube is set in the eluent flow path, and a liquid feeding section for an orthophthalaldehyde solution and a buffer solution with a pH of 7 to 12 is attached upstream thereof. Histamine analyzer. 8. Claim 7, wherein the separation column and mobile phase for liquid chromatography are reversed phase or separation column and mobile phase for cation exchange chromatography.
Analyzer as described in section. 9. The analysis device according to claim 7, wherein the eluent flow path is provided with a heating means capable of heating the eluent to 40 to 70°C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6269485A JPS61219864A (en) | 1985-03-27 | 1985-03-27 | Method and apparatus for analyzing histamine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6269485A JPS61219864A (en) | 1985-03-27 | 1985-03-27 | Method and apparatus for analyzing histamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61219864A JPS61219864A (en) | 1986-09-30 |
| JPH0575066B2 true JPH0575066B2 (en) | 1993-10-19 |
Family
ID=13207656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6269485A Granted JPS61219864A (en) | 1985-03-27 | 1985-03-27 | Method and apparatus for analyzing histamine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61219864A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625737B2 (en) * | 1989-12-27 | 1994-04-06 | 株式会社島津製作所 | Method for analyzing sulfite compounds |
| AU5654099A (en) * | 1998-09-25 | 2000-04-17 | Kikkoman Corporation | Histamine dehydrogenase, process for producing the same, method for quantitatinghistamine and quantification reagent |
| JP4300360B2 (en) * | 2004-05-20 | 2009-07-22 | 財団法人名古屋産業科学研究所 | Histamine detection method and histamine detection kit |
-
1985
- 1985-03-27 JP JP6269485A patent/JPS61219864A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61219864A (en) | 1986-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baeyens et al. | Chemiluminescence-based detection: principles and analytical applications in flowing streams and in immunoassays | |
| Huang et al. | Chemiluminescence detection in capillary electrophoresis | |
| Huang et al. | Chemiluminescence detection for capillary electrophoresis and microchip capillary electrophoresis | |
| Garcı́a-Campaña et al. | Derivatization of biomolecules for chemiluminescent detection in capillary electrophoresis | |
| Li et al. | Highly sensitive trivalent copper chelate-luminol chemiluminescence system for capillary electrophoresis detection of epinephrine in the urine of smoker | |
| Hashimoto et al. | Compact detection cell using optical fiber for sensitization and simplification of capillary electrophoresis–chemiluminescence detection | |
| García‐Campaña et al. | Detection in the liquid phase applying chemiluminescence | |
| Petry-Podgorska et al. | Speciation analysis of mercury employing volatile species generation: Approaches to reliable determination in blood and hair | |
| JPH0154668B2 (en) | ||
| Huclová et al. | Determination of salbutamol using on-line solid-phase extraction and sequential injection analysis. Comparison of chemiluminescence and fluorescence detection | |
| Huclová et al. | Sequential injection extraction based on restricted access material for determination of furosemide in serum | |
| Zacharis et al. | Rapid spectrofluorimetric determination of lisinopril in pharmaceutical tablets using sequential injection analysis | |
| Fernández-del-Campo-García et al. | Combining Orbitrap-HRMS acquisition modes and direct injection by a guard column for targeted analysis of underivatized amino acids in urine | |
| Sato et al. | Determination of metal ions by flow injection analysis with peroxyoxalate chemiluminescence detection | |
| JPH0575066B2 (en) | ||
| JPH0650953A (en) | Glutathione analysis method | |
| Preston et al. | Micellar electrokinetic capillary chromatography with laser-induced fluorimetric detection of amines in beer | |
| WO2005019815A2 (en) | Improvements to liquid chromatography coupled to mass spectrometry in the investigation of selected analytes | |
| JPS61254852A (en) | Histamine analysis method and device | |
| Emara | Determination of methotrexate in pharmaceutical formulations by flow injection analysis exploiting the reaction with potassium permanganate | |
| Díaz et al. | Gas chromatography-combustion-mass spectrometry with postcolumn isotope dilution for compound-independent quantification: its potential to assess HS-SPME procedures | |
| JPH071258B2 (en) | Metal ion analysis method | |
| JP2565446B2 (en) | Catecholamine measurement method | |
| KR100477307B1 (en) | Simultaneous Analysis of Vitamins B1, B2, and B6 Using Partial Post-Column Reactions | |
| JP3355749B2 (en) | Analysis method for catecholamines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |